Heathrow selects Smiths Detection for its next generation cabin baggage and security screening equipment
26.3.2021 10:00:00 EET | Business Wire | Press release
Smiths Detection, a global leader in threat detection and security screening technologies, today announces that it has been chosen to supply integrated checkpoints throughout Heathrow Airport, featuring the HI-SCAN 6040 CTiX computed tomography X-rays, to deliver an advanced level of security and efficiency.
The ECAC EDS CB C3 approved CT systems will see Heathrow meet the highest regulatory requirements, while helping the leading airport achieve its vision for the future of the security checkpoint for passengers and colleagues. The integrated checkpoints feature iLane automatic tray return systems and Checkpoint.Evoplus, Smiths Detection’s checkpoint operation management solution. The award also includes a 10-year equipment service agreement.
“We are delighted to once again be given the opportunity to work closely with Heathrow Airport to provide leading-edge technologies that bring the best security outcomes and passenger experience,” said Smiths Detection President, Roland Carter. “Both Smiths Detection and Heathrow are focused on intelligent solutions that deliver efficiency, security and resilience; and these new lanes will allow for improvements to be easily integrated as technology develops.”
As part of its decision making, Heathrow sought a supplier that could deliver a large scale, innovative, end-to-end solution and integrate the lanes into the airports’ existing operational environment with no impact to capacity or passenger experience.
Each piece of the integrated checkpoint uses Smiths Detection’s leading-edge technology designed to help increase security, improve passenger experience, and enhance operational efficiency:
- HI-SCAN 6040 CTiX – This CT technology cabin baggage screening system provides the highest level of detection using 3D images with low false alarm rates. It delivers advanced explosives detection and can allow for electronics and liquids to remain in bags, helping to expedite the screening process.
- Checkpoint.Evoplus fully integrates the checkpoint by combining individual components of the lane onto a single, intelligent operational management solution. It enables centralised screening by delivering scanned images to operators based at separate locations, resulting in optimised resources management and reduced operational costs.
- iLane - a family of automatic tray return systems that use a modular smart lane design. By delivering a steady flow of trays, iLanes help remove bottlenecks and streamline the screening process to deliver higher throughput. The family includes iLane Selfcair, iLane.evo, and iLane.pro.
This contract is part of a long-term relationship between Heathrow and Smiths Detection, which includes the supply of industry leading hold baggage CT solutions.
The first lanes will be installed in anticipation of a recovery in passenger numbers later this year.
###
About Smiths Detection
Smiths Detection is a global leader in threat detection and screening technologies for aviation, ports and borders, urban security and defence. With more than 40 years of field-tested experience, we deliver the solutions needed to protect society from the threat and illegal passage of explosives, prohibited weapons, contraband, toxic chemicals and narcotics.
Our mission is to help make the world a safer place – we do this by using technology to develop innovative solutions and services which protect life, safeguard society and uphold the free flow of trade.
For more information on Smiths Detection’s solutions and services, visit https://www.smithsdetection.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210326005015/en/
Contact information
Media Contacts
Tom Hufton / Georgina Reeves
FTI Consulting
sc.smithsdetection@fticonsulting.com
+44 (0)20 3727 1000
Sophie Mills
Global Communications Manager
Sophie.mills@smithsdetection.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 09:36:00 EEST | Press release
Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly as possible. “Our discovery of the first orexin agonist is a successful representation of Japan-originated science that will directly impact people around the world living with narcolepsy type 1,” said Julie Kim, president and chief executive officer of Takeda. “With the potential to redefine narcolepsy type 1 care, ORZEYFUL is the first validation of our broader orexin strategy, demonstrating how scientifi
Fasset Hits $1B Valuation as SBI Group Leads $68M Series C to Scale AI-Powered Stablecoin Neobanking24.8.2026 09:03:00 EEST | Press release
Fasset, the AI-powered stablecoin neobanking platform, today announced it has raised $68 million in Series C funding at a $1 billion valuation. The financing was led by SBI Group and follows Fasset’s $51 million Series B earlier this year, which brought Speedinvest onto the cap table alongside a group of strategic investors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823503947/en/ Mohammad Raafi Hossain, Co-Founder and CEO, Fasset The new capital will support the expansion of Own Network, Fasset’s regulated financial network that connects banks, telcos, payment and liquidity providers to enable settlement across international markets. Fasset will also increase investment in agentic AI-enabled systems supporting corridor banking, stablecoin settlement and tokenized asset infrastructure. After raising Series B in May, Fasset has now raised a total of $119 million in 2026. The financing marks Fasset’s entry into the glob
Zanders Expands DACH Region with New Office in Vienna, Austria24.8.2026 08:11:00 EEST | Press release
Zanders, the global treasury, risk, and technology consultancy, today announced a significant expansion of its DACH region with the opening of a new office in Vienna. The move builds on Zanders' continued growth across Germany, Austria, and Switzerland, and marks another step in the firm's strategy of deepening its presence in the markets where client demand for specialized treasury, risk, and corporate finance advisory is growing fastest. DACH has been one of Zanders' priority regions for several years, with the firm steadily expanding its team and client base across Germany and Switzerland. Austria represents a natural next step in that growth: in conversations with clients in the market, Zanders has seen growing interest in treasury transformation and financing support, as companies work through interest rate volatility, refinancing needs, and a broader shift toward more digitized, centralized treasury operations. The new Vienna office allows Zanders to be closer to clients' operati
Novotech Strengthens Presence in Japan with Opening of Tokyo Office24.8.2026 02:01:00 EEST | Press release
Novotech, a leading global biotech CRO and full-service clinical research organization, has strengthened its established presence in Japan with the opening of a new office in Tokyo. The investment builds on Novotech’s existing operations and clinical trial activity in Japan and further enhances its ability to support Japanese biopharma companies as they advance programs regionally and across key international markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260823592174/en/ Takeshi Mori, Novotech Country Head, Japan The Tokyo office will serve as a strategic hub for Novotech’s growing operations in Japan, providing enhanced local expertise and strengthening collaboration with clients, partners, research institutions, and innovation ecosystems across the region. Novotech is currently supporting ongoing studies in Japan and provides sponsors with integrated support across early-phase clinical development in Australia, F
FDA Authorizes ZYN ULTRA Nicotine Pouches Following Scientific Review21.8.2026 22:11:00 EEST | Press release
Philip Morris International Inc. (NYSE: PM) today announces that the U.S. Food and Drug Administration (FDA) issued Marketing Granted Orders to PMI’s U.S. affiliate, Swedish Match USA, Inc., authorizing the marketing of 11 ZYN ULTRA moist oral nicotine pouch products, including all 9mg variants and one 11mg variant. Additional 11mg variants remain under scientific review. Today’s action further enhances PMI’s leadership role in the smoke-free category. “We are delighted with the FDA’s decision to authorize a range of ZYN ULTRA products, which will build on ZYN’s position as America’s leading smoke-free product brand,” said Stacey Kennedy, PMI U.S. CEO. “We look forward to expanding our portfolio of better choices for the 45 million Americans who consume nicotine products.” ZYN ULTRA positions the brand to further extend its category leadership among legal-age consumers of nicotine products. Like the flagship FDA-authorized ZYN pouches, ZYNULTRA, with its higher moisture content, is fre
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
